Shopping Cart
Remove All
Your shopping cart is currently empty
Nesfrotamig is an immunoglobulin (H-γ1-scFv-L-κ) dimer humanized monoclonal antibody that targets human epidermal growth factor receptor 2 (ERBB2) and human tumor necrosis factor receptor superfamily member 9 (TNFRSF9). Nesfrotamig shows potential for use in ERBB2-positive tumor diseases, such as breast cancer and gastric cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Nesfrotamig is an immunoglobulin (H-γ1-scFv-L-κ) dimer humanized monoclonal antibody that targets human epidermal growth factor receptor 2 (ERBB2) and human tumor necrosis factor receptor superfamily member 9 (TNFRSF9). Nesfrotamig shows potential for use in ERBB2-positive tumor diseases, such as breast cancer and gastric cancer. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | ERBB2/TNFRSF9 |
| Cas No. | 2966936-23-0 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.